Keywords: medimmune, asthma, drug, enters, ph, ii, drugmaker

MedImmune's asthma drug enters Ph II and Ph I

Article | 05 May 2008

Print This

US drugmaker MedImmune says it has advanced the development of CAT-354, its potential treatment for asthma, with the start of ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in